These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
468 related articles for article (PubMed ID: 16673803)
1. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. Kasche A; Luderschmidt S; Ring J; Hein R J Drugs Dermatol; 2006 Apr; 5(4):353-6. PubMed ID: 16673803 [TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Moloney FJ; Collins P Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954 [TBL] [Abstract][Full Text] [Related]
3. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial. Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492 [TBL] [Abstract][Full Text] [Related]
4. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe. Lacour JP; Ulrich C; Gilaberte Y; Von Felbert V; Basset-Seguin N; Dreno B; Girard C; Redondo P; Serra-Guillen C; Synnerstad I; Tarstedt M; Tsianakas A; Venema AW; Kelleners-Smeets N; Adamski H; Perez-Garcia B; Gerritsen MJ; Leclerc S; Kerrouche N; Szeimies RM J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2342-8. PubMed ID: 26435363 [TBL] [Abstract][Full Text] [Related]
5. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate. Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244 [TBL] [Abstract][Full Text] [Related]
6. A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis. Torezan L; Grinblat B; Haedersdal M; Valente N; Festa-Neto C; Szeimies RM Br J Dermatol; 2018 Oct; 179(4):829-835. PubMed ID: 29476546 [TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM; Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711 [TBL] [Abstract][Full Text] [Related]
8. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy. Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617 [TBL] [Abstract][Full Text] [Related]
9. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Wiegell SR; Haedersdal M; Philipsen PA; Eriksen P; Enk CD; Wulf HC Br J Dermatol; 2008 Apr; 158(4):740-6. PubMed ID: 18294318 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB; Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399 [TBL] [Abstract][Full Text] [Related]
12. The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp. Kleinpenning MM; van de Kerkhof PC; Gerritsen RM J Dermatolog Treat; 2010 Jul; 21(4):252-7. PubMed ID: 19832288 [TBL] [Abstract][Full Text] [Related]
13. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial. Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730 [TBL] [Abstract][Full Text] [Related]
14. Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT. Lee PK; Kloser A J Drugs Dermatol; 2013 Aug; 12(8):925-30. PubMed ID: 23986167 [TBL] [Abstract][Full Text] [Related]
15. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Morton C; Campbell S; Gupta G; Keohane S; Lear J; Zaki I; Walton S; Kerrouche N; Thomas G; Soto P; Br J Dermatol; 2006 Nov; 155(5):1029-36. PubMed ID: 17034536 [TBL] [Abstract][Full Text] [Related]
16. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Tarstedt M; Rosdahl I; Berne B; Svanberg K; Wennberg AM Acta Derm Venereol; 2005; 85(5):424-8. PubMed ID: 16159735 [TBL] [Abstract][Full Text] [Related]
17. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis. Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440 [TBL] [Abstract][Full Text] [Related]
18. Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study. Pariser D; Loss R; Jarratt M; Abramovits W; Spencer J; Geronemus R; Bailin P; Bruce S J Am Acad Dermatol; 2008 Oct; 59(4):569-76. PubMed ID: 18707799 [TBL] [Abstract][Full Text] [Related]
19. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period. Schmieder GJ; Huang EY; Jarratt M J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520 [TBL] [Abstract][Full Text] [Related]
20. Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial. Buinauskaite E; Zalinkevicius R; Buinauskiene J; Valiukeviciene S Photodermatol Photoimmunol Photomed; 2013 Aug; 29(4):173-81. PubMed ID: 23815349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]